ACAD vs CCL · P/E 15, rev $576.0M vs P/E 15, rev $12.83B
ACADIA Pharmaceuticals Inc (ACAD) versus Carnival Corporation (CCL) — a side-by-side from cached financials, not a winner call.
ACADIA Pharmaceuticals Inc (ACAD) is a biotechnology company listed on US.
Carnival Corporation (CCL) is a travel services company listed on US.
Latest reported ACAD revenue for 2026-06-30 was $576.0M. Net income was $35.1M. ACAD currently screens at market cap $3.51B and trailing P/E 15.3.
Latest reported CCL revenue for 2026-05-31 was $12.83B. Net income was $795.0M. CCL currently screens at market cap $39.74B and trailing P/E 15.3.
ACAD currently screens at market cap $3.51B and trailing P/E 15.3. CCL currently screens at market cap $39.74B and trailing P/E 15.3.
Not investment advice. Open the ACAD and CCL stock pages for the full models.
Not investment advice.